Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to enable synthetic vaccine development in the field of infectious diseases, today announces that it has filed a patent...

A major route toward creating effective vaccines against dengue virus and Zika involves the E protein that covers the surface of each viral particle. If we could develop strong antibodies against this...

PaxVax, a leading independent specialty vaccine company, announced today that it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its vaccine for the prevention...

New research from Public Health Ontario(PHO) and the Institute for Clinical Evaluative Sciences (ICES) suggests that whooping cough cases in Ontario are happening much more frequently than previously...

Scientists at The Scripps Research Institute aim to improve flu and malaria vaccines with the support of a new $12 million grant from the Bill & Melinda Gates Foundation. With the funding, the Scripps...

The measles continue to spread in Europe, because in many countries vaccination coverage is too low. The European Commission has now decided to strengthen its efforts to support the Member States. The...

PaxVax, a leading independent specialty vaccine company, announced today the enrollment of the first patient in its Phase 2b dose-finding trial of the chikungunya virus-like particle (VLP) vaccine,...

As part of its strategic plan to eliminate Cholera in Uganda, Ministry of Health is set to roll out the Oral Cholera Vaccine (OCV) in Cholera prone districts. The districts that will benefit from this...

A publication in Nature Partner Journals (npj) Vaccines indicates that post-exposure prophylaxis with LepVax, IDRI’s leprosy vaccine candidate, not only appears safe but, unlike BCG (a tuberculosis...

The World Health Organization (WHO) published the third report of its Expert Consultation on Rabies, which incorporates the latest recommendations on rabies immunization made in October 2017 by the WHO...